Literature DB >> 26065377

Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer.

C Liu1, X Zhou2, F Gao1, Z Qi1, Z Zhang1, Y Guo1.   

Abstract

The aim of the study is to study the correlation of genetic polymorphism of vascular endothelial growth factor (VEGF) gene with susceptibility to primary lung cancer. A total of 414 patients with primary lung cancer and 338 healthy volunteers were enrolled in this case-control study from September 2008 to October 2011. Gene identification with PCR-RFLP (polymerase chain reaction-based restriction fragment length polymorphism) was used to detect in white blood cells from the subjects the single-nucleotide polymorphisms (SNP) of VEGF gene, including +405G/C, -460 T/C, -1154G/A, -2578C/A sites. Association of genotypes or haplotypes with susceptibility of lung cancer was analyzed with unconditional logistic regression adjusted by gender and age. Smoking was significantly associated with increased risk of lung cancer. Gene phenotypic analysis demonstrated that C allele of +405G/C in VEGF gene was significantly associated increased risk of lung cancer in males (P=0.0094, odds ratio=1.634.3), as that with carrying GCTC haplotype (odds ratio=1.349), whereas carrying GACG had decreased risk for lung cancer (odds ratio=0.044). No relationship existed between 460 T/C, -1154G/A, -2578C/A alleles of VEGF gene and risk of lung cancer. VEGF gene polymorphism may have a role in the development of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26065377     DOI: 10.1038/cgt.2015.24

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  29 in total

1.  C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer.

Authors:  Michael I Koukourakis; Dimitrios Papazoglou; Alexandra Giatromanolaki; Ioannis Panagopoulos; Efstratios Maltezos; Adrian L Harris; Kevin C Gatter; Efthimios Sivridis
Journal:  Lung Cancer       Date:  2006-07-11       Impact factor: 5.705

Review 2.  Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysis.

Authors:  Roberto Iacovelli; Cora N Sternberg; Camillo Porta; Elena Verzoni; Filippo de Braud; Bernard Escudier; Giuseppe Procopio
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

3.  Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts.

Authors:  Steven R Harris; Daniel J Schoeffner; Hitoshi Yoshiji; Unnur P Thorgeirsson
Journal:  Cancer Lett       Date:  2002-05-08       Impact factor: 8.679

Review 4.  VEGF-targeted cancer therapeutics-paradoxical effects in endocrine organs.

Authors:  Yihai Cao
Journal:  Nat Rev Endocrinol       Date:  2014-07-22       Impact factor: 43.330

5.  A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.

Authors:  Takuya Awata; Kiyoaki Inoue; Susumu Kurihara; Tomoko Ohkubo; Masaki Watanabe; Kouichi Inukai; Ikuo Inoue; Shigehiro Katayama
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

6.  The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer.

Authors:  Daniel J Inglis; Tina C Lavranos; Donna M Beaumont; Annabell F Leske; Chloe K Brown; Allison J Hall; Gabriel Kremmidiotis
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

7.  A microRNA-related single nucleotide polymorphism of the XPO5 gene is associated with survival of small cell lung cancer patients.

Authors:  Zhanjun Guo; Hongjing Wang; Yantao Li; Bin Li; Cuiqiao Li; Cuimin Ding
Journal:  Biomed Rep       Date:  2013-03-29

Review 8.  Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review.

Authors:  Zhiwei Chen; Ling Xu; Xiangyun Ye; Shengping Shen; Ziming Li; Xiaomin Niu; Shun Lu
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.

Authors:  Jiali Xu; Zhiqiang Yin; Hong Shen; Wen Gao; Yingying Qian; Dong Pei; Lingxiang Liu; Yongqian Shu
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

10.  Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer.

Authors:  Ananaya Datta-Mitra; Navdeep K Riar; Siba P Raychaudhuri
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

View more
  8 in total

1.  Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.

Authors:  İlknur Bingül; Pervin Vural; Semra Doğru-Abbasoğlu; Esra Çil; Müjdat Uysal
Journal:  J Clin Lab Anal       Date:  2016-12-07       Impact factor: 2.352

2.  Association Between COX-2 Polymorphisms and Lung Cancer Risk.

Authors:  Weiwei Wang; Xinyun Fan; Yong Zhang; Yi Yang; Siyuan Yang; Gaofeng Li
Journal:  Med Sci Monit       Date:  2015-12-01

3.  Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease.

Authors:  Dongxing Liu; Jiantao Song; Xianfei Ji; Zunqi Liu; Mulin Cong; Bo Hu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 4.  Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis.

Authors:  Jingyuan Tang; Zhiqiang Qin; Xiao Li; Peng Han; Feng Wang; Chengdi Yang; Ran Li; Kunpeng Wang; Min Tang; Wei Wang; Qiang Lv; Wei Zhang
Journal:  Oncotarget       Date:  2017-07-25

5.  Vascular Endothelial Growth Factor (VEGF) Gene Promoter Polymorphisms and Disease Progression in North Indian Cohort with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Shewata Pandita; Deepshikha Maurya; Vijaya Ramachandran; Jyotsna Verma; Sudha Kohli; Renu Saxena; Ishwar Chander Verma
Journal:  Int J Mol Cell Med       Date:  2017-09-26

6.  Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population.

Authors:  Fei Liu; Limei Luo; Yonggang Wei; Wentao Wang; Tianfu Wen; Jiayin Yang; Mingqing Xu; Bo Li
Journal:  Oncotarget       Date:  2017-03-07

7.  Correlation of gene polymorphisms of vascular endothelial growth factor with grade and prognosis of lung cancer.

Authors:  Changjiang Liu; Xuetao Zhou; Zefeng Zhang; Yang Guo
Journal:  BMC Med Genet       Date:  2020-04-30       Impact factor: 2.103

8.  Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis.

Authors:  Fengming Yang; Zhiqiang Qin; Chuchu Shao; Weitao Liu; Ling Ma; Yongqian Shu; Hua Shen
Journal:  Biomed Res Int       Date:  2018-06-14       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.